• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体pH值改变激活激肽释放酶-激肽系统:糖尿病性黄斑水肿治疗与发病机制的新视角?:对以下文献的评论:高BB等人。细胞外碳酸酐酶通过激活前激肽释放酶介导视网膜和脑血管出血性通透性增加。《自然医学》。2007年2月;13(2):181 - 8。

Kallikrein-kinin activation by altered vitreous pH: New perspectives for treatment and pathogenesis of diabetic macular edema? : Comment on: Gao BB et al. Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat Med. 2007 Feb;13(2):181-8.

作者信息

Zeitz O, Keserü M

机构信息

Klinik und Poliklinik für Augenheilkunde, Universitätklinikum Hamburg-Eppendorf, Martinitsr. 52, Hamburg 20246, Germany.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2007 Dec;245(12):1745-7. doi: 10.1007/s00417-007-0673-7. Epub 2007 Sep 6.

DOI:10.1007/s00417-007-0673-7
PMID:17823811
Abstract

Recently, Gao et al. published an experimental study based on the pathophysiology of diabetic macular edema in Nature Medicine (Nat Med. 2007 Feb;13(2):181-8). They found an increased amount of carbonic anhydrase in the vitreous, which causes a pH shift. This activates the kallikrein-kinin system and leads to increased retinal vascular permeability. In this comment the clinical implications of this article are discussed.

摘要

最近,高等人在《自然医学》(《自然医学》。2007年2月;13(2):181 - 8)上发表了一项基于糖尿病性黄斑水肿病理生理学的实验研究。他们发现玻璃体内碳酸酐酶的量增加,这会导致pH值变化。这激活了激肽释放酶 - 激肽系统,并导致视网膜血管通透性增加。在这篇评论中,将讨论本文的临床意义。

相似文献

1
Kallikrein-kinin activation by altered vitreous pH: New perspectives for treatment and pathogenesis of diabetic macular edema? : Comment on: Gao BB et al. Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat Med. 2007 Feb;13(2):181-8.玻璃体pH值改变激活激肽释放酶-激肽系统:糖尿病性黄斑水肿治疗与发病机制的新视角?:对以下文献的评论:高BB等人。细胞外碳酸酐酶通过激活前激肽释放酶介导视网膜和脑血管出血性通透性增加。《自然医学》。2007年2月;13(2):181 - 8。
Graefes Arch Clin Exp Ophthalmol. 2007 Dec;245(12):1745-7. doi: 10.1007/s00417-007-0673-7. Epub 2007 Sep 6.
2
Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation.细胞外碳酸酐酶通过激肽释放酶原激活介导视网膜出血和脑血管通透性。
Nat Med. 2007 Feb;13(2):181-8. doi: 10.1038/nm1534. Epub 2007 Jan 28.
3
The Role of Plasma Kallikrein-Kinin Pathway in the Development of Diabetic Retinopathy: Pathophysiology and Therapeutic Approaches.血浆激肽释放酶-激肽途径在糖尿病视网膜病变发生发展中的作用:病理生理学及治疗方法
Semin Ophthalmol. 2016;31(1-2):19-24. doi: 10.3109/08820538.2015.1114829.
4
A prize catch for diabetic retinopathy.糖尿病视网膜病变的重大发现
Nat Med. 2007 Feb;13(2):131-2. doi: 10.1038/nm0207-131.
5
Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema.血浆激肽释放酶-激肽系统作为糖尿病性黄斑水肿的一种不依赖血管内皮生长因子的介质
Diabetes. 2015 Oct;64(10):3588-99. doi: 10.2337/db15-0317. Epub 2015 May 15.
6
[Kallikrein-kinin system as a target for diabetic retinopathy treatment].[激肽释放酶-激肽系统作为糖尿病视网膜病变治疗的靶点]
Vestn Oftalmol. 2012 Jul-Aug;128(4):78-81.
7
Plasma kallikrein and diabetic macular edema.血浆激肽释放酶与糖尿病性黄斑水肿。
Curr Diab Rep. 2010 Aug;10(4):270-5. doi: 10.1007/s11892-010-0127-1.
8
Targeting the kallikrein-kinin system as a new therapeutic approach to diabetic retinopathy.靶向激肽释放酶-激肽系统作为糖尿病视网膜病变的一种新治疗方法。
Curr Opin Investig Drugs. 2010 May;11(5):507-14.
9
Stable and Long-Lasting, Novel Bicyclic Peptide Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular Edema.稳定长效新型双环肽血浆激肽释放酶抑制剂治疗糖尿病性黄斑水肿。
J Med Chem. 2018 Apr 12;61(7):2823-2836. doi: 10.1021/acs.jmedchem.7b01625. Epub 2018 Mar 15.
10
Vascular endothelial growth factor gene polymorphisms and vitreous proteome changes in diabetic retinopathy.糖尿病视网膜病变中血管内皮生长因子基因多态性与玻璃体蛋白质组变化
Semin Ophthalmol. 2013 Sep-Nov;28(5-6):347-54. doi: 10.3109/08820538.2013.825284.

引用本文的文献

1
Diagnosis of tuberculous uveitis by the macrogenome of intraocular fluid: A case report and review of the literature.通过眼内液宏基因组诊断结核性葡萄膜炎:一例病例报告及文献综述
World J Clin Cases. 2023 May 16;11(14):3248-3255. doi: 10.12998/wjcc.v11.i14.3248.

本文引用的文献

1
Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema.改良早期糖尿病性视网膜病变研究与轻度黄斑格栅激光光凝术治疗糖尿病性黄斑水肿的策略比较
Arch Ophthalmol. 2007 Apr;125(4):469-80. doi: 10.1001/archopht.125.4.469.
2
Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up.玻璃体内注射贝伐单抗(阿瓦斯汀)治疗糖尿病性黄斑水肿:泛美视网膜协作研究组6个月随访结果
Ophthalmology. 2007 Apr;114(4):743-50. doi: 10.1016/j.ophtha.2006.12.028.
3
Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation.
细胞外碳酸酐酶通过激肽释放酶原激活介导视网膜出血和脑血管通透性。
Nat Med. 2007 Feb;13(2):181-8. doi: 10.1038/nm1534. Epub 2007 Jan 28.
4
Pathophysiology of diabetic macular edema.
Dev Ophthalmol. 2007;39:1-12. doi: 10.1159/000098495.
5
Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa.继续使用多佐胺治疗色素性视网膜炎患者的黄斑囊样水肿。
Br J Ophthalmol. 2007 Jun;91(6):743-5. doi: 10.1136/bjo.2006.107466. Epub 2007 Jan 10.
6
The economic burden of major adult visual disorders in the United States.美国主要成人视觉障碍的经济负担。
Arch Ophthalmol. 2006 Dec;124(12):1754-60. doi: 10.1001/archopht.124.12.1754.
7
Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.玻璃体内注射贝伐单抗(阿瓦斯汀)治疗持续性弥漫性糖尿病性黄斑水肿。
Retina. 2006 Nov-Dec;26(9):999-1005. doi: 10.1097/01.iae.0000247165.38655.bf.
8
Leading causes of certification for blindness and partial sight in England & Wales.英格兰和威尔士失明及视力部分丧失认证的主要原因。
BMC Public Health. 2006 Mar 8;6:58. doi: 10.1186/1471-2458-6-58.
9
Factors predicting outcome of vitrectomy for diabetic macular oedema: results of a prospective study.预测糖尿病性黄斑水肿玻璃体切除术预后的因素:一项前瞻性研究的结果
Br J Ophthalmol. 2006 Jan;90(1):33-6. doi: 10.1136/bjo.2005.072934.
10
Vitrectomy results for diffuse diabetic macular edema with and without inner limiting membrane removal.有无内界膜剥除的弥漫性糖尿病性黄斑水肿的玻璃体切除术结果
Eur J Ophthalmol. 2004 Mar-Apr;14(2):137-43. doi: 10.1177/112067210401400209.